Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02DWN
|
|||
| Former ID |
DIB007718
|
|||
| Drug Name |
AB-0440a
|
|||
| Synonyms |
TSP-50 targeting monoclonal antibodies (bone loss/osteoporosis); Anti-testes specific protease 50 antibody (boneloss/osteoporosis), Alethia; TSP-50 targeting monoclonal antibodies (bone loss/osteoporosis), Alethia; AB-0440-targeting monoclonal antibodies (bone loss/osteoporosis), Alethia
Click to Show/Hide
|
|||
| Indication | Bone disease [ICD-11: FC0Z; ICD-10: XIII] | Investigative | [1] | |
| Company |
Alethia Biotherapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.